Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alirocumab for Sepsis and Septic Shock
NCT03634293Phase 3Unknown
- Sponsor
- Edith Wolfson Medical Center
- Start
- Jan 2019
- Primary completion
- Jan 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of alirocumab in sepsis, septic shock, sponsored by Edith Wolfson Medical Center. Status: unknown.
02
Drugs
alirocumab
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT03634293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03634293.